Direct determination of kanamycin in raw materials, veterinary formulation and culture media using a novel liquid chromatography–evaporative light scattering method

N.C. Megoulas,M.A. Koupparis
DOI: https://doi.org/10.1016/j.aca.2004.11.031
IF: 6.911
2005-08-01
Analytica Chimica Acta
Abstract:A novel method for the direct determination of kanamycin A and its minor component kanamycin B was developed and validated based on reversed phase liquid chromatography with evaporative light scattering detector (ELSD). ELSD response to kanamycins was found to be enhanced by: (a) decrease of peak width and asymmetry (obtained by controlling the mobile phase acidity or ratio of organic solvent to water), (b) use of ion-pairing acidic reagents of increased molecular mass, and (c) increase of mobile phase volatility. Utilizing an Spherisorb ODS-2 C18 column, the selected optimized mobile phase was water–acetonitrile (60:40, v/v), containing 11.6mM heptafluorobutyric acid (isocratic elution with flow rate of 1.0mlmin−1). Kanamycin A was eluted at 3.9min and kanamycin B at 5.0min with a resolution of 2.7. Logarithmic calibration curves were obtained from 0.6 to 28μgml−1 (r>0.9998) for kanamycin A and 4–36μgml−1 (r>0.9994) for kanamycin B, with a LOD equal to 0.20 and 1.4μgml−1, respectively.In kanamycin acid sulfate pharmaceutical raw materials, the simultaneous determination of sulfate (tR=2.1min, LOD=2.3μgml−1, %R.S.D.=1.7, r>0.9998) and kanamycins was feasible. No significant difference (t-test) was found between the results of the developed LC–ELSD method and those of reference methods, while recovery from kanamycin B spiked samples ranged from 95 to 105%. The developed method was also applied with very good accuracy for the determination of kanamycin A in veterinary formulation (%recovery 95–103, %R.S.D.<1.4, n=3) and for the determination of kanamycins A and B in bacteria culture media (%recovery 102 and 99, respectively).
chemistry, analytical
What problem does this paper attempt to address?